rs942519

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015404.4(WHRN):​c.1838T>C​(p.Met613Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.536 in 1,613,758 control chromosomes in the GnomAD database, including 234,027 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 18272 hom., cov: 32)
Exomes 𝑓: 0.54 ( 215755 hom. )

Consequence

WHRN
NM_015404.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.24

Publications

45 publications found
Variant links:
Genes affected
WHRN (HGNC:16361): (whirlin) This gene is thought to function in the organization and stabilization of sterocilia elongation and actin cystoskeletal assembly, based on studies of the related mouse gene. Mutations in this gene have been associated with autosomal recessive non-syndromic deafness and Usher Syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
WHRN Gene-Disease associations (from GenCC):
  • Usher syndrome type 2D
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • autosomal recessive nonsyndromic hearing loss 31
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.9923813E-6).
BP6
Variant 9-114406753-A-G is Benign according to our data. Variant chr9-114406753-A-G is described in ClinVar as Benign. ClinVar VariationId is 45663.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.561 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WHRNNM_015404.4 linkc.1838T>C p.Met613Thr missense_variant Exon 9 of 12 ENST00000362057.4 NP_056219.3 Q9P202-1B9EGE6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WHRNENST00000362057.4 linkc.1838T>C p.Met613Thr missense_variant Exon 9 of 12 1 NM_015404.4 ENSP00000354623.3 Q9P202-1

Frequencies

GnomAD3 genomes
AF:
0.485
AC:
73752
AN:
151974
Hom.:
18256
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.364
Gnomad AMI
AF:
0.570
Gnomad AMR
AF:
0.494
Gnomad ASJ
AF:
0.613
Gnomad EAS
AF:
0.505
Gnomad SAS
AF:
0.576
Gnomad FIN
AF:
0.491
Gnomad MID
AF:
0.554
Gnomad NFE
AF:
0.540
Gnomad OTH
AF:
0.500
GnomAD2 exomes
AF:
0.529
AC:
132256
AN:
249862
AF XY:
0.536
show subpopulations
Gnomad AFR exome
AF:
0.360
Gnomad AMR exome
AF:
0.520
Gnomad ASJ exome
AF:
0.607
Gnomad EAS exome
AF:
0.499
Gnomad FIN exome
AF:
0.494
Gnomad NFE exome
AF:
0.544
Gnomad OTH exome
AF:
0.533
GnomAD4 exome
AF:
0.542
AC:
791630
AN:
1461664
Hom.:
215755
Cov.:
99
AF XY:
0.544
AC XY:
395471
AN XY:
727110
show subpopulations
African (AFR)
AF:
0.359
AC:
12020
AN:
33480
American (AMR)
AF:
0.519
AC:
23192
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
0.605
AC:
15798
AN:
26132
East Asian (EAS)
AF:
0.536
AC:
21281
AN:
39692
South Asian (SAS)
AF:
0.596
AC:
51369
AN:
86242
European-Finnish (FIN)
AF:
0.493
AC:
26316
AN:
53354
Middle Eastern (MID)
AF:
0.570
AC:
3285
AN:
5764
European-Non Finnish (NFE)
AF:
0.545
AC:
606210
AN:
1111936
Other (OTH)
AF:
0.533
AC:
32159
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
27214
54428
81642
108856
136070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17182
34364
51546
68728
85910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.485
AC:
73800
AN:
152094
Hom.:
18272
Cov.:
32
AF XY:
0.482
AC XY:
35876
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.364
AC:
15098
AN:
41482
American (AMR)
AF:
0.494
AC:
7554
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.613
AC:
2126
AN:
3470
East Asian (EAS)
AF:
0.505
AC:
2601
AN:
5148
South Asian (SAS)
AF:
0.579
AC:
2793
AN:
4826
European-Finnish (FIN)
AF:
0.491
AC:
5205
AN:
10594
Middle Eastern (MID)
AF:
0.561
AC:
165
AN:
294
European-Non Finnish (NFE)
AF:
0.540
AC:
36694
AN:
67966
Other (OTH)
AF:
0.495
AC:
1045
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1960
3920
5881
7841
9801
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.526
Hom.:
54813
Bravo
AF:
0.482
TwinsUK
AF:
0.546
AC:
2023
ALSPAC
AF:
0.559
AC:
2156
ESP6500AA
AF:
0.387
AC:
1703
ESP6500EA
AF:
0.546
AC:
4695
ExAC
AF:
0.529
AC:
64172
Asia WGS
AF:
0.479
AC:
1667
AN:
3478
EpiCase
AF:
0.541
EpiControl
AF:
0.546

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
May 31, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 19, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal recessive nonsyndromic hearing loss 31 Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Usher syndrome type 2D Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.84
T
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.4
DANN
Benign
0.18
DEOGEN2
Benign
0.047
.;.;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0095
N
LIST_S2
Benign
0.019
T;T;T
MetaRNN
Benign
0.0000070
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.69
.;.;N
PhyloP100
1.2
PrimateAI
Benign
0.26
T
PROVEAN
Benign
0.45
N;N;N
REVEL
Benign
0.054
Sift
Benign
0.53
T;T;T
Sift4G
Benign
0.53
T;T;T
Polyphen
0.0
.;B;B
Vest4
0.014
MPC
0.14
ClinPred
0.0037
T
GERP RS
0.056
Varity_R
0.042
gMVP
0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs942519; hg19: chr9-117169033; COSMIC: COSV54327986; API